(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 5.64% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.47%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.
Revvity's revenue in 2026 is $2,856,051,000.On average, 20 Wall Street analysts forecast RVTY's revenue for 2026 to be $339,422,899,464, with the lowest RVTY revenue forecast at $322,093,996,494, and the highest RVTY revenue forecast at $350,938,234,986. On average, 20 Wall Street analysts forecast RVTY's revenue for 2027 to be $356,416,404,312, with the lowest RVTY revenue forecast at $332,938,535,772, and the highest RVTY revenue forecast at $373,745,307,282.
In 2028, RVTY is forecast to generate $377,322,887,250 in revenue, with the lowest revenue forecast at $353,956,818,084 and the highest revenue forecast at $398,788,367,058.